243 results on '"Indrák K"'
Search Results
2. Morphology of Megakaryocytes in Chronic Myeloproliferative Diseases
3. Mutace v epigenetických regulátorech - potenciální prognostické markery a terapeutické cíle u akutní myeloidní leukemie.
4. Double fusion signal BCR/ABL, detected by FISH on chromosomes 9 and 22 in a child with ALL
5. The WHO 2008 classification of Ph-myeloproliferative disorders: statement of the Czech MPD Working Group
6. Abdominal zygomycotic thromboangiitis in a patient with AML and t(1;13;14)
7. Additional evidence of genetic changes in children with ALL and TEL/AML1 fusion gene
8. Second Autologous Transplantation for Multiple Myeloma Patients Relapsing after the First Autograft - a Pilot Study for the Evaluation of Experimental Maintenance Therapies: Report of the Prospective Non-Randomized Pilot Study of the Czech Myeloma Group
9. High-dose consolidation chemotherapy with autologous transplantation after intensive sequential induction therapy improves complete remission rate in patients with poor prognosis non-Hodgkin lymphomas
10. Contribution of Comparative Genomic Hybridization and Fluorescence in situ Hybridization to the Detection of Chromosomal Abnormalities in B-Cell Chronic Lymphocytic Leukemia
11. Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases
12. Hb Nottingham or α2β2 98 (FG5) Val→Gly in a Czech child
13. Vývoj léčby chronické myeloidní leukemie v posledních 25 letech.
14. Selective depletion of alloreactive T cells and study of anti-tumor activity of specific T cell clones in patients with leukemia
15. Immune Escape Mechanisms in Diffuse Large B-Cell Lymphoma
16. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
17. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow
18. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma]
19. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up
20. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report)
21. Oral Compliacation after Bone Marrow Transplantation
22. 334 The importance of prognostic parametres for the allogeneic transplantation course in patients with myelodysplastic syndromes and secondary acute leukemia
23. P.086 Salivary neutrophils – indicator of a bone marrow engraftment
24. P013 All-transretinoic acid (ATRA) in the treatment of acute promyelocytic leukemia - 15 years of single centre experience
25. P027 A new international registry for patients with chronic myeloid leukemia: CAMELIA
26. P081 Spontaneous splenic rupture in two patients with hematologic malignancy
27. P029 Treatment of chronic myeloid leukemia with interferon and imatinib: results from the northern Moravia
28. O39 Treatment of chronic myeloid leukemia in Northern Moravia: results during the period 1990 2005
29. P123 CAMELIA: a new international registry for patients with chronic myeloid leukemia
30. O51 Acute myeloid leukemia in the Czech Republic and the Slovak Republic from 1996 to 2007. Prognostic and therapeutic results of 1890 patients from the ALERT registry
31. P022 An influence of cytokine polymorphism on the outcome of allografted patients
32. High Incidence of Unbalanced Chromosomal Changes in Mantle Cell Lymphoma Detected by Comparative Genomic Hybridization
33. Chronická myelomonocytová leukémia -- prehľad súčasných diagnostických a liečebných možností.
34. Toxoplazma a imunodeficience, kazuistika.
35. Maligní nádory vzniklé po úspěšné léčbě akutní myeloidní leukemie u dospělých nemocných: dlouhodobé zkušenosti jednoho pracoviště.
36. 165 Immunotherapy with low-dose interleukin-2 in patients with myelodysplastic syndromes RAEB and RAEB-T (an ongoing pilot study)
37. Současná léčba myelofibrózy na základĕ rizikové stratifikace pacientů.
38. Hodnocení časné molekulární odpovědi po 3 měsících léčby imatinibem může u nemocných s chronickou myeloidní leukemií přispět k upřesnění odhadu prognózy -- zkušenosti jednoho centra.
39. Genetické polymorfismy destičkových receptorů u mladých pacientů s akutním infarktem myokardu (AIM) a rezistencí k protidestičkové léčbě.
40. Immune EscapeMechanisms in Diffuse Large B-Cell Lymphoma.
41. Klinický význam génových mutácií u akútnych myeloidných leukémií s normálnym karyotypom.
42. Orální komplikace po alogenní transplantaci kostní dřenĕ.
43. Léčba pacientů s relabovaným/refraktérním Hodgkinovým lymfomem.
44. High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the lymphoma working party of the European Group for Blood and Marrow Transplantation.
45. High Incidence of Unbalanced Chromosomal Changes in Mantle Cell Lymphoma Detected by Comparative Genomic Hybridization.
46. Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia – the Retrospective Analysis
47. Comparison of Conditioning Regimens BU-CY and FLU-BU12-TG Used in the Patients Undergoing Allogeneic Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML)
48. 187: Fludarabin and Cyclophosphamide Based Non-Myeloablative Conditioning Regimens in the Patients Allografted for Recurrent/Refractory Malignant Lymphoproliferative Disorders
49. Podpůrná terapie megestrol acetátem u myeloproliferativních neoplazií.
50. The Role of Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Waldenström's Macroglobulinemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.